FR - Doxiciclina, una alternativa efectiva, bien tolerada y de bajo coste como tratamiento de primera línea del penfigoide ampolloso
Authors:
- 1 July 2018
- journal article
- editorial
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 109 (6) , 549-550
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trialThe Lancet, 2017
- A randomised controlled trial to compare the safety, effectiveness and cost-effectiveness of doxycycline (200 mg/day) with that of oral prednisolone (0.5 mg/kg/day) for initial treatment of bullous pemphigoid: the Bullous Pemphigoid Steroids and Tetracyclines (BLISTER) trialHealth Technology Assessment, 2017
- Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and VenereologyBritish Journal of Dermatology, 2015
- Clinical applications of non-antimicrobial tetracyclines in dermatologyPharmacological Research, 2011
- A Comparison of Oral and Topical Corticosteroids in Patients with Bullous PemphigoidNew England Journal of Medicine, 2002